JP Morgan analyst Lisa Gill maintains Elevance Health (NYSE:ELV) with a Overweight and raises the price target from $628 to $631.
JP Morgan Maintains Overweight on Elevance Health, Raises Price Target to $631
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.